Published in J Am Coll Cardiol on May 01, 1991
Reentry in an accessory atrioventricular pathway as a trigger for atrial fibrillation initiation in manifest Wolff-Parkinson-White syndrome: a matter of reflection? Heart Rhythm (2008) 0.85
Relationship between accessory pathway location and occurrence of atrial fibrillation in patients with atrioventricular re-entrant tachycardia. Exp Clin Cardiol (2004) 0.75
Assessment of atrial fibrillation and vulnerability in patients with Wolff-Parkinson-White syndrome using two-dimensional speckle tracking echocardiography. PLoS One (2014) 0.75
Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome. J Interv Card Electrophysiol (2009) 0.75
Sudden cardiac death. Circulation (1998) 9.41
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22
Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J (1982) 6.79
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol (1997) 4.00
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med (2000) 3.84
Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet (2000) 3.71
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med (1992) 2.96
High-density mapping of electrically induced atrial fibrillation in humans. Circulation (1994) 2.94
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 2.85
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation (1998) 2.67
Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med (1999) 2.39
17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation (2001) 2.39
Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res (2000) 2.35
Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery. Am Heart J (1989) 2.35
Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med (1974) 2.30
Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation (1997) 2.29
Social support, depression, and mortality during the first year after myocardial infarction. Circulation (2000) 2.25
The value of the right precordial leads of the electrocardiogram. N Engl J Med (1999) 2.20
The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med (1978) 2.20
At what time are implantable defibrillator shocks delivered? Evidence for individual circadian variance in sudden cardiac death. Eur Heart J (1995) 2.12
Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation (1972) 2.09
Structural alterations in the latissimus dorsi muscles in three patients more than 2 years after a cardiomyoplasty procedure. Eur Heart J (1998) 2.02
Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J (1995) 1.99
The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation (1967) 1.96
Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg (2001) 1.92
Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med (2001) 1.91
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med (1997) 1.86
The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway. Pacing Clin Electrophysiol (1994) 1.84
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83
Transcoronary chemical ablation of atrioventricular conduction. Circulation (1990) 1.76
The electrocardiogram in patients with multiple accessory atrioventricular pathways. J Am Coll Cardiol (1990) 1.73
Longitudinal dissociation of atrioventricular accessory pathways. J Am Coll Cardiol (1991) 1.65
Effect of digitalis on atrioventricular conduction and circus-movement tachycardias in patients with Wolff-Parkinson-White syndrome. Circulation (1973) 1.65
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation (1991) 1.64
Delayed effects of radiofrequency energy: mechanisms and clinical implications. Pacing Clin Electrophysiol (1996) 1.62
How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med (1996) 1.62
Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries. Eur Heart J (2002) 1.61
Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation (2000) 1.61
The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol (1995) 1.60
Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.60
Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation (1995) 1.59
Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res (2000) 1.57
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation (2001) 1.57
Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation (1975) 1.57
Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation. Am J Cardiol (1974) 1.56
Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. J Am Coll Cardiol (1999) 1.55
Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome. Circulation (1992) 1.55
A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J (2000) 1.54
Brugada syndrome: a decade of progress. Circ Res (2002) 1.54
Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1988) 1.53
Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation (1997) 1.51
Value of the 12-lead electrocardiogram at hospital admission in the diagnosis of pulmonary embolism. Am J Cardiol (1994) 1.51
Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion. Heart (2009) 1.51
Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res (1997) 1.51
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation (2000) 1.51
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J (2002) 1.50
Lead aVR, a mostly ignored but very valuable lead in clinical electrocardiography. J Am Coll Cardiol (2001) 1.48
Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol (1990) 1.48
Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation (1999) 1.47
[Panic disorder in patients with chest pain and palpitations: an often unrecognized relationship]. Ned Tijdschr Geneeskd (2000) 1.47
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol (1996) 1.47
The anatomical substrates of wolff-parkinson-white syndrome. A clinicopathologic correlation in seven patients. Circulation (1978) 1.47
Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol (1990) 1.46
Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol (2000) 1.46
Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol (1995) 1.46
Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol (2000) 1.45
Coronary artery bypass grafting and defibrillator implantation in patients with ventricular tachyarrhythmias and ischemic heart disease. Pacing Clin Electrophysiol (1999) 1.44
Changing characteristics and in-hospital outcome in patients admitted with acute myocardial infarction. Observations from 1982 to 1994. Eur Heart J (1997) 1.44
Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation (1985) 1.43
Repolarizing K+ currents ITO1 and IKs are larger in right than left canine ventricular midmyocardium. Circulation (1999) 1.43
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol (2001) 1.42
"Tachycardiomyopathy". The most frequently unrecognized cause of heart failure? Acta Cardiol (1993) 1.42
Transcoronary chemical ablation of ventricular tachycardia. Circulation (1989) 1.42
Current therapeutic strategies in severe acute pancreatitis. Intensive Care Med (1990) 1.41
Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol (1976) 1.41
Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy: assessment by pressure-volume loops. J Am Coll Cardiol (2000) 1.40
Sudden cardiac death: do we have to change our tactics? Cardiologia (1996) 1.39
Bedside recordings of His-bundle electrograms using conventional twelve-lead surface electrocardiography. J Cardiovasc Electrophysiol (1994) 1.39
High uniformity of left and right ventricular repolarization dynamics induced by an abrupt decrease in pacing cycle length in a dog is not affected by left ventricular ischemia. J Cardiovasc Electrophysiol (2000) 1.38
Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator. J Am Coll Cardiol (1998) 1.38
Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias. Eur Heart J (2000) 1.38